Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sesen Bio Inc (NQ: SESN )

0.5162 +0.0162 (+3.24%)
Streaming Delayed Price Updated: 11:12 AM EDT, May 26, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 740,873
Open 0.5100
Bid (Size) 0.5162 (7)
Ask (Size) 0.5181 (118)
Prev. Close 0.5000
Today's Range 0.4907 - 0.5223
52wk Range 0.3650 - 6.040
Shares Outstanding 196,002,620
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Sesen Bio: Q1 Earnings Insights
Sesen Bio (NASDAQ:SESN) reported its Q1 earnings results on Monday, May 9, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Sesen Bio Reports First Quarter 2022 Financial Results and Business Update
From Sesen Bio
Via Business Wire

Performance

YTD
-39.65%
-39.65%
1 Month
+17.91%
+17.91%
3 Month
-15.98%
-15.98%
6 Month
-52.86%
-52.86%
1 Year
-82.26%
-82.26%

More News

Read More
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Sesen Bio: Q4 Earnings Insights
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
80 Biggest Movers From Yesterday
Via Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
Via Benzinga
Sesen Bio Provides Strategic Update
From Sesen Bio
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Sesen Bio Reports Fourth Quarter and Full-Year 2021 Financial Results and Anticipated Regulatory Path Forward for the Company’s Lead Product Candidate, Vicineum™
From Sesen Bio
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Sesen Bio Further Enhances Team with Key Hires
From Sesen Bio
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
6 of the Best Penny Stocks Under $1 to Buy Now for 2022
Via InvestorPlace
Why Sesen Bio Stock Got Slammed Today
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Sesen Bio To Conduct Additional Trial For Potential Resubmission Of Vicineum In Bladder Cancer
Via Benzinga
Sesen Bio Announces Anticipated Regulatory Path Forward for Vicineum™
From Sesen Bio, Inc.
Via Business Wire
7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts
Via InvestorPlace
Exposures COVID-19
7 Penny Stocks with 10x Potential in 2022
Via InvestorPlace
Topics Electric Vehicles
Exposures Electric Vehicles
Sesen Bio Strengthens Medical Team
From Sesen Bio
Via Business Wire
Sesen Bio Director Jane Pritchett Henderson Transitions to CEO Advisor Role
From Sesen Bio
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.